Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML

Recent advances have resulted in an expansion of treatment options for AML, especially targeted therapies and low-intensity regimens. At JADPRO Live Virtual 2021, presenters reviewed novel and targeted oral chemotherapy for adults with AML and discussed multidisciplinary collaboration for patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryant, Ashley Leak, Buhlinger, Kaitlyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126336/
https://www.ncbi.nlm.nih.gov/pubmed/35663185
http://dx.doi.org/10.6004/jadpro.2022.13.3.31
_version_ 1784712104531460096
author Bryant, Ashley Leak
Buhlinger, Kaitlyn
author_facet Bryant, Ashley Leak
Buhlinger, Kaitlyn
author_sort Bryant, Ashley Leak
collection PubMed
description Recent advances have resulted in an expansion of treatment options for AML, especially targeted therapies and low-intensity regimens. At JADPRO Live Virtual 2021, presenters reviewed novel and targeted oral chemotherapy for adults with AML and discussed multidisciplinary collaboration for patients with complex AML chemotherapy regimens.
format Online
Article
Text
id pubmed-9126336
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-91263362022-06-04 Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML Bryant, Ashley Leak Buhlinger, Kaitlyn J Adv Pract Oncol Meeting Reports Recent advances have resulted in an expansion of treatment options for AML, especially targeted therapies and low-intensity regimens. At JADPRO Live Virtual 2021, presenters reviewed novel and targeted oral chemotherapy for adults with AML and discussed multidisciplinary collaboration for patients with complex AML chemotherapy regimens. Harborside Press LLC 2022-04 2022-05-23 /pmc/articles/PMC9126336/ /pubmed/35663185 http://dx.doi.org/10.6004/jadpro.2022.13.3.31 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Bryant, Ashley Leak
Buhlinger, Kaitlyn
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
title Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
title_full Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
title_fullStr Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
title_full_unstemmed Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
title_short Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With AML
title_sort role of the advanced practitioner in the management of oral chemotherapy for adults with aml
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126336/
https://www.ncbi.nlm.nih.gov/pubmed/35663185
http://dx.doi.org/10.6004/jadpro.2022.13.3.31
work_keys_str_mv AT bryantashleyleak roleoftheadvancedpractitionerinthemanagementoforalchemotherapyforadultswithaml
AT buhlingerkaitlyn roleoftheadvancedpractitionerinthemanagementoforalchemotherapyforadultswithaml

Ejemplares similares